  0 Table of Contents |
  1 Home |
| 2 Mapping |
| 3 Logical Models |
| 4 Data Model (ERD) |
 5 Artifacts Summary |
 5.1 BioSample logical model |
| 5.2 ClinicalVariable logical model |
| 5.3 ConcomitantDisease logical model |
| 5.4 ConcomitantEpisode logical model |
| 5.5 ConcomitantMedication logical model |
| 5.6 Donor logical model |
| 5.7 EpigenomeStudy logical model |
| 5.8 GenomicTest logical model |
| 5.9 ImmIndPat logical model |
| 5.10 ImmMainPat logical model |
| 5.11 Immunosuppressant logical model |
| 5.12 InstrumentalInvestigation logical model |
| 5.13 LabResult logical model |
| 5.14 LabTest logical model |
| 5.15 MarkImmFunc logical model |
| 5.16 MethylomicStudy logical model |
| 5.17 Microbiology logical model |
| 5.18 Outcome logical model |
| 5.19 OutcomeType logical model |
| 5.20 Patient logical model |
| 5.21 PatInstInv logical model |
| 5.22 PostEvent logical model |
| 5.23 PostEventType logical model |
| 5.24 PreMedication logical model |
| 5.25 ReferenceGenome logical model |
| 5.26 TargetRegion logical model |
| 5.27 Transplant logical model |
| 5.28 Unit logical model |
| 5.29 VariantAnnotation logical model |
| 5.30 VariantOccurrence logical model |
| 5.31 Visit logical model |
| 5.32 ABO group observation |
| 5.33 Biological Sample |
| 5.34 Clinical Variable |
| 5.35 Concomitant Disease |
| 5.36 Concomitant Episode |
| 5.37 Concomitant Medication |
| 5.38 Donor liver graft type observation |
| 5.39 Donor pre-KTX dialysis type observation |
| 5.40 Epigenome Study |
| 5.41 Genomic Test |
| 5.42 Histological diagnosis date observation |
| 5.43 HLA Class I typing observation |
| 5.44 HLA Class II typing observation |
| 5.45 Immunosuppressant |
| 5.46 Immunosuppressant Induction to Patient |
| 5.47 Immunosuppressive Maintenance to Patient |
| 5.48 Instrumental Investigation |
| 5.49 Lab Result |
| 5.50 Lab Test |
| 5.51 Laboratory DiagnosticReport |
| 5.52 Liver disease diagnosis observation |
| 5.53 Marker of Immune Function |
| 5.54 Methylomic Study |
| 5.55 Microbiology |
| 5.56 Outcome |
| 5.57 Outcome Type |
| 5.58 Patient Instrumental Investigation |
| 5.59 Patient observations |
| 5.60 Post Event |
| 5.61 Post Event Type |
| 5.62 PRA observation |
| 5.63 Pre-transplant Medication |
| 5.64 Reference Genome |
| 5.65 Renal disease diagnosis observation |
| 5.66 Rh factor observation |
| 5.67 Target Region |
| 5.68 Transplant |
| 5.69 Transplant Donor |
| 5.70 Transplant Recipient |
| 5.71 Variant Annotation |
| 5.72 Variant Occurrence |
| 5.73 Visit |
| 5.74 2h post-dose drug level (C2) |
| 5.75 Adenovirus serology IgG |
| 5.76 Adenovirus serology IgM |
| 5.77 AECA / other non-HLA antibodies |
| 5.78 Age at DNA extraction |
| 5.79 Alignment tools |
| 5.80 Allele frequency |
| 5.81 Alternate allele |
| 5.82 Annotation database |
| 5.83 Annotation databases |
| 5.84 Annotation tools |
| 5.85 Anti-MICA antibody result |
| 5.86 Anti-MICB antibody result |
| 5.87 Antihypertensive treatment |
| 5.88 Antiviral prophylaxis pre-medication |
| 5.89 Area under the concentration–time curve (AUC) |
| 5.90 Array date |
| 5.91 AT1R antibody result |
| 5.92 Beta value |
| 5.93 BioSample ID relationship |
| 5.94 Bisulfite date |
| 5.95 Bisulfite reference kit |
| 5.96 BKV FISH on kidney biopsy |
| 5.97 BKV-DNA on kidney biopsy |
| 5.98 Blood BKV-DNA |
| 5.99 Blood CMV-DNA |
| 5.100 Blood EBV-DNA |
| 5.101 Blood Parvovirus B19-DNA |
| 5.102 Chip type |
| 5.103 Chromosome coordinate |
| 5.104 Chromosome ID |
| 5.105 Clinical variable ID relationship |
| 5.106 Clinical variable ID relationship |
| 5.107 CMV serology IgG |
| 5.108 CMV serology IgM |
| 5.109 CNV locus |
| 5.110 Cold ischaemia time (minutes) |
| 5.111 Concomitant disease ID relationship |
| 5.112 Concomitant disease name(s) |
| 5.113 Concomitant episode ID relationship |
| 5.114 Concomitant episode ID relationship |
| 5.115 Concomitant episode ID relationship |
| 5.116 Copy number |
| 5.117 Date |
| 5.118 Date of instrumental investigation |
| 5.119 dbSNP rsID |
| 5.120 Detection p-value |
| 5.121 Diastolic blood pressure |
| 5.122 DNA concentration |
| 5.123 Donor ID relationship |
| 5.124 Donor type |
| 5.125 Donor-specific antibody (DSA) |
| 5.126 Donor/recipient weight ratio |
| 5.127 Dose of immunosuppressant |
| 5.128 EBV serology IgG anti-VCA |
| 5.129 EBV serology IgG EBNA |
| 5.130 EBV serology IgM anti-EA |
| 5.131 EBV serology IgM anti-VCA |
| 5.132 End date of maintenance therapy |
| 5.133 End position |
| 5.134 Epigenome Study ID Relationship |
| 5.135 Episode date |
| 5.136 Episode description |
| 5.137 ETAR antibody result |
| 5.138 Event description |
| 5.139 Event end date |
| 5.140 Event onset date |
| 5.141 First warm ischaemia time (minutes) |
| 5.142 Fusion breakpoint |
| 5.143 Fusion supporting reads |
| 5.144 Genetic origin |
| 5.145 Genomic Test ID Relationship |
| 5.146 Genomic test ID relationship |
| 5.147 Genomic test ID relationship |
| 5.148 Genomic Test Name |
| 5.149 Genomic Test Version |
| 5.150 Genotype |
| 5.151 Heart rate |
| 5.152 Height |
| 5.153 HGNC ID |
| 5.154 HGNC symbol |
| 5.155 HGVS c. notation |
| 5.156 HGVS p. notation |
| 5.157 HLA antibody class or locus |
| 5.158 HSV serology IgG |
| 5.159 HSV serology IgM |
| 5.160 Immunosuppressant dose |
| 5.161 Immunosuppressant ID relationship |
| 5.162 Immunosuppressant ID relationship |
| 5.163 Immunosuppressant name |
| 5.164 Immunosuppressive induction ID relationship |
| 5.165 Immunosuppressive maintenance ID relationship |
| 5.166 Instrumental investigation ID relationship |
| 5.167 Instrumental investigation name |
| 5.168 Intraoperative complications |
| 5.169 Kidney side |
| 5.170 Lab result ID relationship |
| 5.171 Lab result patient reference |
| 5.172 Lab test ID relationship |
| 5.173 Lab test name |
| 5.174 Lab test reference |
| 5.175 M value |
| 5.176 Manifest number |
| 5.177 Mean target coverage |
| 5.178 Medication |
| 5.179 Medication |
| 5.180 Methylated reads |
| 5.181 Methylomic Study ID Relationship |
| 5.182 MFI value |
| 5.183 Microbiology ID relationship |
| 5.184 Microbiology ID relationship |
| 5.185 Nephrectomy of original kidney |
| 5.186 Other intraoperative complications (free text) |
| 5.187 Other pre-transplant medications |
| 5.188 Outcome date |
| 5.189 Outcome ID relationship |
| 5.190 Outcome type ID relationship |
| 5.191 Outcome type name |
| 5.192 Oxygen saturation |
| 5.193 Parvovirus B19 serology IgG |
| 5.194 Parvovirus B19 serology IgM |
| 5.195 Patient ID relationship |
| 5.196 Patient ID relationship |
| 5.197 Patient ID relationship |
| 5.198 Patient ID relationship |
| 5.199 Patient ID relationship |
| 5.200 Patient ID relationship |
| 5.201 Patient ID relationship |
| 5.202 Patient ID relationship |
| 5.203 Patient instrumental investigation ID relationship |
| 5.204 Patient instrumental investigation ID relationship |
| 5.205 Per target base cover x100 |
| 5.206 Pool ID |
| 5.207 Post event ID relationship |
| 5.208 Post event type ID relationship |
| 5.209 Post event type name |
| 5.210 Post-event ID relationship |
| 5.211 Pre-dose drug level |
| 5.212 Pre-medication ID relationship |
| 5.213 Pre-medication ID relationship |
| 5.214 Pre-medication patient reference |
| 5.215 Raw data |
| 5.216 Read count |
| 5.217 Read length |
| 5.218 Read type |
| 5.219 Recipient patient reference |
| 5.220 Reference allele |
| 5.221 Reference genome FASTA path |
| 5.222 Reference Genome ID relationship |
| 5.223 Reference genome ID relationship |
| 5.224 Reference sequence |
| 5.225 Result of the instrumental investigation |
| 5.226 Rituximab pre-medication |
| 5.227 Sample ID |
| 5.228 Sample send to INGEMM date |
| 5.229 Sample type |
| 5.230 Scan date |
| 5.231 Second warm ischaemia time (minutes) |
| 5.232 Sentrix barcode array |
| 5.233 Sentrix position |
| 5.234 Sequence alteration |
| 5.235 Sequencing device |
| 5.236 SNP reader device |
| 5.237 Start date of maintenance therapy |
| 5.238 Start position |
| 5.239 Systolic blood pressure |
| 5.240 Target capture |
| 5.241 Target disease ID |
| 5.242 Target region ID |
| 5.243 Target region ID relationship |
| 5.244 Temperature |
| 5.245 Time from diagnosis to transplant (months) |
| 5.246 Transplant donor reference |
| 5.247 Transplant ID relationship |
| 5.248 Type of surgical biliary anastomosis |
| 5.249 Unit ID relationship |
| 5.250 Urine BKV-DNA |
| 5.251 Variant calling tools |
| 5.252 Variant class level |
| 5.253 Variant exon number |
| 5.254 Variant feature |
| 5.255 Variant occurrence ID relationship |
| 5.256 Variant origin |
| 5.257 Variant pathogenicity |
| 5.258 Variant read depth |
| 5.259 Variant tier level |
| 5.260 Vascular anomalies |
| 5.261 Vessel mismatch (donor-recipient) |
| 5.262 VZV serology IgG |
| 5.263 VZV serology IgM |
| 5.264 Weight |
| 5.265 ABO Group ValueSet |
| 5.266 BioSample Tissue Type ValueSet |
| 5.267 Concomitant Disease Category ValueSet |
| 5.268 Concomitant Medication Category ValueSet |
| 5.269 Dialysis method ValueSet |
| 5.270 Donor Liver Type ValueSet |
| 5.271 Donor type value set |
| 5.272 Immunosuppressant Drug Type |
| 5.273 Immunosuppressive Maintenance to Patient Type ValueSet |
| 5.274 Instrumental Investigation Name |
| 5.275 Intraoperative Complications ValueSet |
| 5.276 Kidney Side ValueSet |
| 5.277 Lab Result Unit ValueSet |
| 5.278 Lab Test Name |
| 5.279 Outcome Type Name |
| 5.280 Patient Instrumental Investigation Result ValueSet |
| 5.281 Post Event Type Name |
| 5.282 PRA Observation Type ValueSet |
| 5.283 Pre-medication Antihypertensive Drug ValueSet |
| 5.284 Pre-medication Type ValueSet |
| 5.285 Reference Genome Build ValueSet |
| 5.286 Rh Factor ValueSet |
| 5.287 Transplant Type ValueSet |
| 5.288 Type of surgical biliary anastomosis ValueSet |
| 5.289 Visit Type ValueSet |
| 5.290 ABO Group CodeSystem |
| 5.291 BioSample Tissue Type CodeSystem |
| 5.292 Concomitant Disease Category |
| 5.293 Concomitant Medication Category |
| 5.294 Donor Liver Type CodeSystem |
| 5.295 Donor type |
| 5.296 Immunosuppressant Drug Type |
| 5.297 Immunosuppressive Maintenance to Patient Type CodeSystem |
| 5.298 Instrumental Investigation Name |
| 5.299 Intraoperative Complications CodeSystem |
| 5.300 Kidney Side CodeSystem |
| 5.301 Lab Test Name |
| 5.302 Outcome Type Name |
| 5.303 Patient Instrumental Investigation Result CodeSystem |
| 5.304 Post Event Type Name |
| 5.305 PRA Observation Type CodeSystem |
| 5.306 Pre-medication Antihypertensive Drug CodeSystem |
| 5.307 Pre-medication Type CodeSystem |
| 5.308 Reference Genome Build CodeSystem |
| 5.309 Rh Factor CodeSystem |
| 5.310 Transplant Type CodeSystem |
| 5.311 Type of surgical biliary anastomosis CodeSystem |
| 5.312 Visit Type CodeSystem |
| 5.313 Example Biological Sample |
| 5.314 Example Clinical Variables |
| 5.315 Example Concomitant Disease |
| 5.316 Example Concomitant Episode |
| 5.317 Example Concomitant Medication |
| 5.318 Example donor ABO observation |
| 5.319 Example donor HLA class I typing |
| 5.320 Example donor HLA class II typing |
| 5.321 Example donor liver graft type |
| 5.322 Example donor observations list |
| 5.323 Example donor PRA observation |
| 5.324 Example donor pre-KTX dialysis type |
| 5.325 Example donor Rh observation |
| 5.326 Example Epigenome Study |
| 5.327 Example Genomic Test |
| 5.328 Example histological diagnosis date |
| 5.329 Example Immunosuppressant |
| 5.330 Example Immunosuppressant Induction to Patient |
| 5.331 Example Immunosuppressive Maintenance to Patient |
| 5.332 Example Instrumental Investigation |
| 5.333 Example Lab Result Observation |
| 5.334 Example Lab Test |
| 5.335 Example Laboratory Report |
| 5.336 Example liver disease diagnosis |
| 5.337 Example Marker of Immune Function |
| 5.338 Example Methylomic Study |
| 5.339 Example Microbiology record |
| 5.340 Example Outcome |
| 5.341 Example Outcome Type |
| 5.342 Example patient ABO observation |
| 5.343 Example patient HLA class I typing |
| 5.344 Example patient HLA class II typing |
| 5.345 Example Patient Instrumental Investigation |
| 5.346 Example patient last PRA observation |
| 5.347 Example patient max PRA observation |
| 5.348 Example patient observations list |
| 5.349 Example patient Rh observation |
| 5.350 Example Post Event Type |
| 5.351 Example Post-Transplant Event |
| 5.352 Example Pre-medication |
| 5.353 Example Reference Genome GRCh38 |
| 5.354 Example renal disease diagnosis |
| 5.355 Example Target Region |
| 5.356 Example transplant |
| 5.357 Example transplant donor |
| 5.358 Example transplant recipient |
| 5.359 Example Variant Annotation |
| 5.360 Example Variant Occurrence |
 5.361 Example visit |
